drug
loteprednol etabonate
Marketedupdated 5mo agoby $ALC ALCON INC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6all catalysts(1)
Trials studying loteprednol etabonate
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 3, 2033
~6.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (32)
- Dec 23, 2036formulationUS 10596107
- Jan 26, 2036formulationUS 11534395
- May 3, 2033formulationUS 10058511
- May 3, 2033formulationUS 10058511
- May 3, 2033formulationUS 10646436
- May 3, 2033formulationUS 10646437
- May 3, 2033formulationUS 10688045
- May 3, 2033formulationUS 10688045
- May 3, 2033method-of-use (U-2985)US 10857096
- May 3, 2033method-of-use (U-3011)US 10864219
- May 3, 2033method-of-use (U-2985)US 10940108
- May 3, 2033method-of-use (U-2985)US 10945948
- May 3, 2033method-of-use (U-3117)US 10993908
- May 3, 2033method-of-use (U-2985)US 11219596
- May 3, 2033method-of-use (U-3279)US 11219597
- May 3, 2033method-of-use (U-2985)US 11596599
- May 3, 2033formulationUS 11642317
- May 3, 2033formulationUS 11642317
- May 3, 2033formulationUS 11872318
- May 3, 2033formulationUS 11872318
- May 3, 2033formulationUS 12115246
- May 3, 2033formulationUS 12115246
- May 3, 2033formulationUS 9056057
- May 3, 2033formulationUS 9056057
- May 3, 2033formulationUS 9393213
- May 3, 2033formulationUS 9393213
- May 3, 2033method-of-use (U-2491)US 9532955
- May 3, 2033method-of-use (U-2491)US 9532955
- May 3, 2033method-of-use (U-2492)US 9737491
- May 3, 2033method-of-use (U-2492)US 9737491
- May 3, 2033formulationUS 9827191
- May 3, 2033formulationUS 9827191
FDA exclusivities (1)
- Jul 14, 2026CGTCGT
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that